New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Proton Pump Inhibitors, Gastric Pre-Cancerous Lesions

It has been suggested that long-term use of proton pump inhibitors (PPIs) may promote the development of pre-cancerous lesions in the stomach and increase the occurrence of stomach cancer.

Vaccine Could Prevent Most Cervical Cancers

A vaccine meant to protect against nine types of human papillomavirus (HPV) could prevent 90% of all cervical cancers.

Obese CRC Patients, Second Cancer Risk

Colorectal cancer (CRC) patients who are overweight or obese when diagnosed appear to face a slightly higher risk for developing a second weight-related cancer.

ASTRO: New Choosing Wisely Guidelines

The American Society for Radiation Oncology (ASTRO) has released a second list of five radiation oncology-specific treatments that should be discussed before being prescribed.

Yogurt Test as Novel Colonoscopy Alternative ...

Synthetic biomarkers combined with yogurt may one day replace or augment colonoscopies and improve early diagnosis of colorectal cancer.

Do E-Cigarettes Help Cancer Patients Quit?

Smokers with cancer who used e-cigarettes along with traditional cigarettes were more dependent on nicotine than those who didn't use the devices, and were just as likely - or less likely - to have quit smoking than patients who didn't use e-cigarettes.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

Erwinaze Gains IV Administration Approval

Erwinaze Gains IV Administration Approval

Jazz announced that the Food and Drug Administration has approved the intravenous (IV) administration of Erwinaze (asparaginase Erwinia chrysantheum).

'Financial Toxicity' Impacting Some Cancer Patients

'Financial Toxicity' Impacting Some Cancer Patients

The cost of cancer treatment can cause financial stress that threatens patients' well-being, according to a new study.

First-in-Class Drug for Advanced Ovarian Cancer Approved

First-in-Class Drug for Advanced Ovarian Cancer Approved

The Food and Drug Administration (FDA) has granted accelerated approval for Lynparza (olaparib; AstraZeneca) for the treatment of advanced ovarian cancer associated with defective BRCA genes.

SLNB May Not Up Survival in Melanoma Arising in Head, Neck

SLNB May Not Up Survival in Melanoma Arising in Head, Neck

New research suggests that for patients with melanoma arising in head and neck subsites (HNM), there is no association between sentinel lymph node biopsy (SLNB) and disease-specific survival (DSS).

Good Long-Term Outcomes with LCR for Bladder Cancer

Good Long-Term Outcomes with LCR for Bladder Cancer

For patients with bladder cancer, laparoscopic radical cystectomy (LRC) is associated with good long-term outcomes.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 23.00 Credits

Sign Up for Free e-newsletters